You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

IVABRADINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Ivabradine Hydrochloride

A generic version of IVABRADINE HYDROCHLORIDE was approved as ivabradine hydrochloride by ANNORA PHARMA on October 5th, 2022.

  Try a Trial

Drug patent expirations by year for IVABRADINE HYDROCHLORIDE
Recent Clinical Trials for IVABRADINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Second Affiliated Hospital of Guangzhou Medical UniversityPhase 4
Uniformed Services University of the Health SciencesPhase 4
The Young Investigator Group of Cardiovascular ResearchPhase 3

See all IVABRADINE HYDROCHLORIDE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for IVABRADINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for IVABRADINE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CORLANOR Tablets ivabradine hydrochloride 5 mg and 7.5 mg 206143 6 2019-10-15

US Patents and Regulatory Information for IVABRADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Annora Pharma IVABRADINE HYDROCHLORIDE ivabradine hydrochloride TABLET;ORAL 213366-001 Oct 5, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ingenus Pharms Llc IVABRADINE HYDROCHLORIDE ivabradine hydrochloride TABLET;ORAL 214051-002 Dec 30, 2021 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Annora Pharma IVABRADINE HYDROCHLORIDE ivabradine hydrochloride TABLET;ORAL 213366-002 Oct 5, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ingenus Pharms Llc IVABRADINE HYDROCHLORIDE ivabradine hydrochloride TABLET;ORAL 214051-001 Dec 30, 2021 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms IVABRADINE HYDROCHLORIDE ivabradine hydrochloride TABLET;ORAL 213442-002 Nov 29, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms IVABRADINE HYDROCHLORIDE ivabradine hydrochloride TABLET;ORAL 213442-001 Nov 29, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.